Trevi Therapeutics (TRVI) Stock Forecast for 2028. Trvi Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Trevi Therapeutics, Inc. (TRVI) Stock Forecast for 2028. Trvi Shares Prediction

Updated: April 19, 2024 (06:05)

Sector: Healthcare

The share price of Trevi Therapeutics, Inc. (TRVI) now

What analysts predict: $7.33
52-week High/Low: $4 / $0.97

50/200 Day Moving Average: $2.83 / $2.062

This figure corresponds to the Average Price over the previous 50/200 days. For Trevi Therapeutics stocks, the 50-day moving average is the resistance level today.

For Trevi Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Trevi Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Trevi Therapeutics stock price in 2028. How much will one Trevi Therapeutics share be worth in 2028? Is it worth taking profit / loss on TRVI stock now or waiting? What are analysts' forecasts for Trevi Therapeutics stock?

We forecast Trevi Therapeutics stock performance using neural networks based on historical data on TRVI stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Trevi Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Trevi Therapeutics analysts is $7.33. Today 200 Day Moving Average is the support level (2.062 $). 50 Day Moving Average is the support level (2.83 $).




Historical and forecast chart of Trevi Therapeutics, Inc. stock

The chart below shows the historical price of Trevi Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the TRVI stock price can be found in the table below.


Trevi Therapeutics (TRVI) Forecast for 2028

Month Target Pes. Opt. Vol., %
Jan 2.73 2.49 3.04 18.04 %
Feb 2.34 1.79 2.80 36.31 %
Mar 2.21 1.78 2.70 34.29 %
Apr 2.62 2.19 2.85 23.39 %
May 3.26 2.54 3.76 32.52 %
Jun 3.58 3.26 4.00 18.48 %
Jul 3.14 2.47 3.68 32.96 %
Aug 2.73 2.09 3.38 38.08 %
Sep 2.90 2.71 3.14 13.56 %
Oct 2.43 2.15 2.74 21.58 %
Nov 1.76 1.34 1.89 29.02 %
Dec 1.51 1.24 1.65 24.98 %

Trevi Therapeutics information and performance

Trevi Therapeutics Address

195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT, US

Market Capitalization: 177 917 000 $

Market capitalization of the Trevi Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TRVI shares in the company outstanding by the market price of one share.

EBITDA: -33 800 000 $

EBITDA of Trevi Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.29

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.189

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 68960000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Trevi Therapeutics price target for 2028 by month


Target values for the price of one Trevi Therapeutics share for Jan 2028.

The weighted average target price per Trevi Therapeutics share in Jan 2028 is: 2.73.
In Jan, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.043% volatility is expected.
Pessimistic target level: 2.49
Optimistic target level: 3.04

Target values for the price of one Trevi Therapeutics share for Feb 2028.

The weighted average target price per Trevi Therapeutics share in Feb 2028 is: 2.34.
In Feb, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 36.311% volatility is expected.
Pessimistic target level: 1.79
Optimistic target level: 2.80

Target values for the price of one Trevi Therapeutics share for Mar 2028.

The weighted average target price per Trevi Therapeutics share in Mar 2028 is: 2.21.
In Mar, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 34.286% volatility is expected.
Pessimistic target level: 1.78
Optimistic target level: 2.70

Target values for the price of one Trevi Therapeutics share for Apr 2028.

The weighted average target price per Trevi Therapeutics share in Apr 2028 is: 2.62.
In Apr, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.395% volatility is expected.
Pessimistic target level: 2.19
Optimistic target level: 2.85

Target values for the price of one Trevi Therapeutics share for May 2028.

The weighted average target price per Trevi Therapeutics share in May 2028 is: 3.26.
In May, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 32.524% volatility is expected.
Pessimistic target level: 2.54
Optimistic target level: 3.76

Target values for the price of one Trevi Therapeutics share for Jun 2028.

The weighted average target price per Trevi Therapeutics share in Jun 2028 is: 3.58.
In Jun, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.482% volatility is expected.
Pessimistic target level: 3.26
Optimistic target level: 4.00

Target values for the price of one Trevi Therapeutics share for Jul 2028.

The weighted average target price per Trevi Therapeutics share in Jul 2028 is: 3.14.
In Jul, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 32.964% volatility is expected.
Pessimistic target level: 2.47
Optimistic target level: 3.68

Target values for the price of one Trevi Therapeutics share for Aug 2028.

The weighted average target price per Trevi Therapeutics share in Aug 2028 is: 2.73.
In Aug, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 38.076% volatility is expected.
Pessimistic target level: 2.09
Optimistic target level: 3.38

Target values for the price of one Trevi Therapeutics share for Sep 2028.

The weighted average target price per Trevi Therapeutics share in Sep 2028 is: 2.90.
In Sep, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 13.561% volatility is expected.
Pessimistic target level: 2.71
Optimistic target level: 3.14

Target values for the price of one Trevi Therapeutics share for Oct 2028.

The weighted average target price per Trevi Therapeutics share in Oct 2028 is: 2.43.
In Oct, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.581% volatility is expected.
Pessimistic target level: 2.15
Optimistic target level: 2.74

Target values for the price of one Trevi Therapeutics share for Nov 2028.

The weighted average target price per Trevi Therapeutics share in Nov 2028 is: 1.76.
In Nov, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.023% volatility is expected.
Pessimistic target level: 1.34
Optimistic target level: 1.89

Target values for the price of one Trevi Therapeutics share for Dec 2028.

The weighted average target price per Trevi Therapeutics share in Dec 2028 is: 1.51.
In Dec, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.977% volatility is expected.
Pessimistic target level: 1.24
Optimistic target level: 1.65



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.